Skip to contentI
INSMED Inc
I
INSMINSMED Inc Source filing unavailable
Q4 2014 · —
Revenue—
Net Income-$17.65M-$17.65MN/M vs Q4 2013 EPS Diluted-$0.36-$0.36N/M vs Q4 2013 Operating Income-$23,066,000N/M Operating Cash Flowderived-$12,932,000N/M Free Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
-$14,469,000
N/M